Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30002482HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30074614HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30074615HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30019425HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30018938HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30019001HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30074617HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30040824HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30040825HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TVIS30040826HIVENSG00000005844.19protein_codingITGALNoNo3683P20701
TCGA Plot Options
Drug Information
GeneITGAL
DrugBank IDDB01098
Drug NameRosuvastatin
Target IDBE0000516
UniProt IDP20701
Regulation Typeinhibitory allosteric modulator
PubMed IDs11385505; 15041742; 15822172
CitationsWeitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada Y, Hommel U: Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001 Jun;7(6):687-92. doi: 10.1038/89058.@@Katano H, Pesnicak L, Cohen JI: Simvastatin induces apoptosis of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines and delays development of EBV lymphomas. Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4960-5. Epub 2004 Mar 23.@@Liao JK, Laufs U: Pleiotropic effects of statins. Annu Rev Pharmacol Toxicol. 2005;45:89-118. doi: 10.1146/annurev.pharmtox.45.120403.095748.
GroupsApproved
Direct ClassificationPhenylpyrimidines
SMILESCC(C)C1=NC(=NC(C2=CC=C(F)C=C2)=C1C=C[C@@H](O)C[C@@H](O)CC(=O)O)N(C)S(C)(=O)=O
PathwaysRosuvastatin Action Pathway
PharmGKBPA134308647
ChEMBLCHEMBL1496